Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CFTR | P13569 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14958982 | 0.92 | ALDH1A1 (0.37) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29557419 | 0.92 | CA12 (0.35) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28367230 | 0.92 | CA12 (0.35) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29557234 | 0.90 | CA12 (0.34) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11684908 | 0.83 | CA1 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15358293 | 0.83 | CA12 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11168943 | 0.82 | LMNA (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3403381 | 0.79 | CA12 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9387753 | 0.78 | CFTR (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11549333 | 0.77 | KDM4E (0.31) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687672-A1 | RADIOPAQUE POLYSACCHARIDE HYDROGELS AND METHODS OF MAKING THE SAME | Boston Scientific Scimed Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| US-20250249130-A1 | RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-08-07 | — | — | US | disclosed |
| US-20250059237-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-02-20 | — | — | US | disclosed |
| WO-2025038709-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-02-20 | — | — | WO | disclosed |
| WO-2024211688-A1 | RADIOPAQUE POLYSACCHARIDE HYDROGELS AND METHODS OF MAKING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| US-20240335568-A1 | RADIOPAQUE POLYSACCHARIDE HYDROGELS AND METHODS OF MAKING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-10 | — | — | US | disclosed |
| CN-110903275-A | Process for producing iobitridol, intermediate therefor, and process for producing the same | 苏州科伦药物研究有限公司 | 2020-03-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335568-A1 | RADIOPAQUE POLYSACCHARIDE HYDROGELS AND METHODS OF MAKING THE SAME | CD44, ALG1, CA13 | CA12 13/4885CA1 73/4885CA2 544/4885 |
| US-20250059237-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM | HDGF, IAPP, QRFPR | CA12 1869/4885CA1 2660/4885CA2 4132/4885 |
| US-20250249130-A1 | RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS | IAPP, IGFBP6, NPPA | CA12 520/4885CA1 1262/4885CA2 3237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.